Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Feel that heat.
And power.
Makes one anxious.
You know, with BP getting ivolved with turning waste plastic into oil, I'm beginning to think PTOI may become a $539 wonder.
BP knows a thing or two.
Time to buy.
$100 guaranteed!
539%.
Plastic To Resin (not Oil) can, and will, make money.
Trust me.
Looking good for NNVC.
Now if we can just get China, North Korea and Trump on our side.
And Russia.
And the FDA!
A piece of cake.
They needed the money to pay their high priced shills Friedman and Stapp.
It is amazing, how such an alleged scam, cum fraud, like OSCI, garners the aid and support and attention, of such renowned institutions and people (like me!).
Absolutely amazing.
Makes one think.
Even if they pay for it.
You get what you pay for.
Reputations are on line, too.
Just like here.
--30--
--†--
Turn out the lights:
Osceola Gold Inc 0.0614 USD -0.0235 (-27.68%) 20.00KOSCI
I like the fact MIT is involved in this technology.
Right! MIT. Whodathought!!
Ref:
"MASSACHUSETTS INST TECHNOLOGY [US]"
https://worldwide.espacenet.com/publicationDetails/biblio?CC=WO&NR=2017070676A1&KC=A1&FT=D&ND=3&date=20170427&DB=EPODOC&locale=en_EP
In some embodiments, the amph-NPs are utilized to deliver an antimicrobial active agent for treatment of a disease or infection. Lymph nodes filter the lymph, can carry bacteria, viruses, or other microbes. At sites of infection, large numbers of these microbial organisms collect in the regional lymph nodes and produce the local swelling and tenderness typical of a localized infection. Enlarged and occasionally confluent lymph nodes (lymphadenopathy) are often referred to as the "swollen glands" associated with diagnosis of infection. Depending on their location in the body, swollen lymph nodes are visible or identifiable by touch.
The amph-NP can be used to treat infection by, for example, delivering to infected lymph nodes, a small molecule drug that can reduce an infection, by for example, killing the microorganism or an infected cell carrying the microorganism. The infection can be, for example, a viral infection, bacterial infection, fungal, or protozoa infection. Thus, some embodiments provides a method for treating infection by administering to a subject an amount of an active agent-load Amph-NP to reduce one or more symptoms of the activity in the subject.
And THE US ARMY:
http://www.siliconinvestor.com/readmsg.aspx?msgid=31542126
This invention was made with government support under grant No. W911NF-13-D-0001 (Project 6927308) from the U.S. Army. The government has certain rights in the invention.
Is this a good short or a good bye?
Shit works!
Too much competition.
NNVC is working on it.
Cheap shit.
Moffat is working on it.
Results soon.
The cides were initially designed as drug carriers (Theracour indictes carriers). As it turned out during testing, the drug was unnecessary for viral eradication! And so cides were born!!
There is a plethora of other treatments for cancer, bacteria, et al where the drug will be included and perform the treatment; we are barely scratching the surface presently.
Now, to actually use a virus itself as the drug/carrier opens up many more possibilities!
I trust Meyers and Vyas have these offshoots in mind! I don't think Diwan does. At least not inside NNVC.
These female supporters of NNVC are an amazing group:
Meeta Vyas/CFO/Future CEO(?)
Jenny Moffat/NNVC HSV researcher
Caroline Myers/NNVC analyst/Future CEO(?)
Zika virus could help combat brain cancer
February 21, 2018
By Elton Alisson | Agência FAPESP
Zika virus, feared for causing microcephaly in babies whose mothers were infected during pregnancy by attacking the cells that will give rise to the fetus’s cerebral cortex, could be an alternative for treatment of glioblastoma, the most common and aggressive kind of malignant brain tumor in adults.
This discovery was made by researchers at the University of Campinas’s School of Pharmaceutical Sciences (FCF-UNICAMP) in São Paulo State, Brazil. Resulting from a Thematic Project supported by FAPESP, the study is described in an article posted to bioRxiv, a preprint repository for the biological sciences, and accepted for publication by Journal of Mass Spectrometry.
“Zika virus, which has become a threat to health in the Americas, could be genetically modified to destroy glioblastoma cells,” said Rodrigo Ramos Catharino, a professor at FCF-UNICAMP and head of the institution’s Innovare Biomarker Laboratory.
Previous research conducted recently in Brazil and elsewhere points to increased mortality rates for human neural progenitor cells (hNPCs) infected by Zika virus, as well as growth inhibition and morphological abnormalities.
Alterations in these cells, which are precursors of brain cells and become cortical neurons in embryos and fetuses, may be a cause of microcephaly in babies whose mothers have been infected by Zika. Other studies have shown that the virus is capable of moving into brain cells, modifying the regulation of the cell cycle, and inducing their death.
In light of these findings, the researchers at FCF-UNICAMP set out to investigate the effects of Zika virus when it infects glioblastoma cells. To do this, they infected human malignant glioblastoma cells with Zika and recorded microscope images of them 24 hours and 48 hours after infection in order to observe any metabolic alterations (cytopathic effects) caused by inoculation of the virus.
The results of the analysis showed that the glioblastoma cells displayed moderate cytopathic effects 24 hours after infection, such as rounded, swollen cell bodies and formation of syncytia, masses of cytoplasm in which the membrane contains several nuclei.
The most severe cytopathic effects were observed 48 hours after infection, with a larger number of rounded, swollen cells, more syncytium formation and pronounced loss of cell integrity, all of which denote cell death.
“The cytopathic effects of Zika infection on glioblastoma cells were observed most clearly after 48 hours. Cell morphology was almost totally altered during this period,” Catharino said.
Key molecule
To identify the main compounds (metabolites) produced by glioblastoma cells during infection by Zika, the researchers analyzed the cells using matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI).
The technique consists of breaking down the atoms or molecules in a sample so that they become charged with more or fewer electrons than the original (ionization) and then separating them by mass/charge ratio in order to identify and quantify them.
The mass spectrometry data were submitted to statistical analysis, which showed that 24 hours after infection, the cells began to produce cardiac glycosides, especially digoxin.
Previous in vitro studies conducted by researchers in other countries showed that this molecule was able to reduce the multiplication and increase the mortality of cells from melanoma, the most aggressive type of skin cancer, as well as breast cancer and neuroblastoma, a tumor that typically affects patients aged 15 or younger.
Because digoxin and other cardiac glycosides have been shown to induce cancer cell death, the researchers concluded that infection by Zika triggered synthesis of the molecule in glioblastoma cells and that this phenomenon is probably one of the factors that lead to neuronal cell death. “Digoxin could be the key molecule that activates glioblastoma cell death during Zika infection,” Catharino said.
Based on these findings, the researchers suggest that a genetically engineered Zika virus could eliminate the effects of infection and leave only the viral particles that synthesize digoxin. Thus, the virus could be an alternative for the treatment of glioblastoma, which is highly resistant to chemotherapy drugs.
“The use of oncolytic viruses [viruses genetically engineered to destroy tumor cells] is at an advanced stage, especially to treat skin cancer and myeloma [bone marrow cancer],” Catharino said. “Zika could be a candidate for the treatment of glioblastoma.”
The article “Zika virus infection induces synthesis of digoxin in glioblastoma cells” (doi: 10.1101/174441) by Estela Lima, Tatiane M. Guerreiro, Carlos Melo, Diogo N. de Oliveira, Daisy Machado, Marcelo Lancellotti and Rodrigo Catharino can be retrieved from bioRxiv at biorxiv.org/content/early/2017/08/09/174441.
https://www.biorxiv.org/content/early/2017/08/09/174441
The article “MALDI imaging detects endogenous digoxin in glioblastoma cells infected by Zika virus – would it be the oncolytic key?” (doi: 10.1002/jms.4058) by Estela Lima, Tatiane M. Guerreiro, Carlos Melo, Diogo N. de Oliveira, Daisy Machado, Marcelo Lancellotti and Rodrigo Catharino is available from Journal of Mass Spectrometry at onlinelibrary.wiley.com/doi/10.1002/jms.4058/full.
http://agencia.fapesp.br/zika_virus_could_help_combat_brain_cancer/27166/
It is amazing, how such an alleged scam, cum fraud, NNVC, garners the aid and support and attention, of such renowned institutions and people (like me!).
Absolutely amazing.
Makes one think.
Even if NNVC pays for it.
You get what you pay for.
Reputations are on line, too - NNVC's and the august orgs doing their research requests.
Full speed ahead
"Successful testing of our drug candidates in animal models of the dermal, ocular, and genital herpesvirus diseases at the University of Wisconsin would enable us to rapidly move these drug candidates towards human clinical trials," said Dr. Anil R. Diwan, President and Chairman of the Company, adding, "This will further bolster our pipeline and increase the total value of our HerpeCide assets several-fold, with minimal additional investments. The expansion of our agreement with the CORL at University of Wisconsin is thus very significant for creating substantially increased business value."
This is no joke; this is criminal.
And I await the torrent of accolades and compliments that will undoubtedly flow from the accomplishments to come from this CFO handling the refinanced, revitalised, NNVC and the newly crowned CEO (Myers?).
That will be a treat to see.
Tributes unlimited but well deserved, each and every one.
The FDA will blush!
Meeta Vyas, NNVC CFO, an outstanding record of accomplishment.
Meeta Vyas
CFO, NanoViricides, Inc.
Greater New York City Area
Pharmaceuticals
Current
Nanoviricides, Inc
Previous
The Gores Group, Kamylon Capital, LLC, MRV Partners
Education
Columbia Business School
Recommendations 1 person has recommended Meeta Vyas
223
connections
View Meeta Vyas’ full profile. It's free!
Your colleagues, classmates, and 500 million other professionals are on LinkedIn.
View Meeta’s Full Profile
Summary
CFO, proven Private Equity Operating Partner and former PE Portfolio Company CEO delivers: EBITDA growth; Business Unit revenue increases and total cost reduction; productivity gains and lean six sigma manufacturing; performance improvement across all functions; international growth strategy; supply chain optimization; and M&A Due Diligence.
Expertise:
Corporate financial management; performance improvement in Private Equity Portfolio Companies in multiple industries as Operating Partner of The Gores Group ($4B assets, middle market cos) and Portfolio Manager at Kamylon Capital ($1B, lower middle market cos); Turnaround skills implemented as CEO at PE firm Thomas H Lee's portfolio company 'Signature Brands' (aka 'Mr. Coffee' and 'HealthOMeter' with Revenues > $280 Million and China sourcing) leading to its acquisition; Operations excellence delivered as General Manager of a General Electric business unit (Revenues > $1 Billion, 5 brands, Mexico and USA manufacturing facilities) resulting in a doubling of Operating Income in < 2 years; Strategy development tools from McKinsey; and Supply Chain Management successes in USA, India, China, & Mexico.
Education:
MIT (BS, Chemical Engineering); Columbia University (MBA, Finance)
Specialties: See above
Experience
Chief Financial Officer
Nanoviricides, Inc
May 2013 – Present (4 years 11 months)
Responsible for assisting investor cultivation, improving bank interactions, and optimizing administrative functions including Human Resources, Supplier and Service Provider management, intracompany processes, etc.
The Gores Group
Principal
The Gores Group
January 2012 – December 2012 (1 year)
Drive cross-functional Performance Improvement at Portfolio Companies in North America and Europe in various manufacturing industries, and perform Due Diligence of new investments for $4 Billion fund.
Kamylon Capital, LLC
Director, Portfolio Management
Kamylon Capital, LLC
2009 – 2011 (2 years)
Drive Performance Improvement at 4 Portfolio Companies at this Private Equity firm with $1.1 Billion
Partner
MRV Partners
2005 – 2009 (4 years)
Growth, Operations, and Turnarounds expertise for Private Equity portfolios, Corporations, and Not-For-Profits
Vice President, Living Oceans Program
National Audubon Society
2003 – 2004 (1 year)
Marine conservation programs for pelagic species
Secretary General & CEO
Worldwide Fund For Nature WWF-India
2000 – 2002 (2 years)
Largest NGO dedicated to nature conservation in India with over 30 State Offices and programs dedicated to: Tiger & Wildlife, Forests, Freshwater & Wetlands, Oceans, Education, Environmental Law, and more.
CEO & Vice Chairman of the Board of PE firm THLee's portfolio company
Signature Brands (aka "Mr. Coffee" & "HealthOMeter"
1997 – 1999 (2 years)
Delivered total turnaround of the company by transforming Sales, Marketing, new Product Development, Manufacturing Operations in Cleveland and Chicago, Supply Chain in USA and China, logistics and distribution, etc in one year leading to its acquisition by Sunbeam Corp
General Electric
General Manager
General Electric
1991 – 1997 (6 years)
Delivered Revenues of over $1 Billion and doubled Operating Income from $75 Million to $150 Million in under 2 years by increasing productivity in N.A. manufacturing plants including joint venture in Mexico, increasing inventory turnover & quality, initiating 5-year strategic plan including $100 Million new development, etc. program, and more.
McKinsey & Company
Consultant
McKinsey & Company
1987 – 1991 (4 years)
Assistant Portfolio Manager
Fisher
1984 – 1987 (3 years)
Exxon
Process Design Engineer
Exxon
1980 – 1982 (2 years)
Education
Columbia Business School
Columbia Business School
MBA, Finance
1982 – 1984
Massachusetts Institute of Technology
Massachusetts Institute of Technology
SB, Chemical Engineering
1976 – 1980
Skills
Portfolio Company Performance ImprovementDue DiligencePrivate EquityMergersInvestmentsVenture CapitalCorporate FinanceMergers & AcquisitionsEntrepreneurshipFinancial AnalysisBusiness StrategyTurn Around ManagementPerformance ImprovementStart-upsRestructuringSee 29+
How's this translation?Great•Has errors
Recommendations
A preview of what LinkedIn members have to say about Meeta:
Meeta assisted our company with several kaizen events and operational improvements that resulted in very positive change. She brings intelligence, energy and great people skills to her engagements that made it a delight to work with her. She has strong leadership skills that could help almost any organization.
See more
Sign up to see who recommended Meeta
Groups
General Electric Alumni
General Electric Alumni
Private Equity, M&A, and Venture Capital Investments
Private Equity, M&A, and Venture Capital Investments
MIT Massachusetts Institute of Technology Alumni
MIT Massachusetts Institute of Technology Alumni
https://www.linkedin.com/in/meeta-vyas-19244811
As with all of these shill driven scams the final disposition is way off into the future with plenty zeroes appearing in the stock price. A lingering death.
As with all these slow to die shill tactics.
Actually, I have no doubts at all about that.
The FDA is our friend!
Trust me.
I trust the test results will bring the FDA on board favourably.
They will keep it up till the SEC puts them out of business.
539% certainty.
This company is located in Florida and is the 2nd biggest joke down there.
539% accurate.
I'm still waiting for that 539% increase I've heard about!
I'm real good at waiting, fortunately.
The main shill for OSCI has a 539% record of failure!
And he is only one of many!!
That bid is at least 539% accurate!
Friedman guarantees it.
IBM: How Bitcoin Could Make Big Blue a Big Buy
IBM could be a low-risk way to play blockchain
https://investorplace.com/2017/09/ibm-bitcoin-big-buy/#.WqMTGujwY2w
Don't believe it - Bitcoin/Blockchain/NNVC is a scam operated by slobbering geriatric old fools.
It will never happen - Fake News!!
Their tech is almost (not quite) identical.
It just makes sense, maybe, to cooperate/collaborate/integrate/save money.
To me anyway.
Otherwise let the courts decide the issue?
I'd like to see what Myers thinks.
Perhaps I am FOS???!
Background
The IBM nanomedicine polymer program - which started in IBM's Research labs four years ago with the mission to improve human health – stems from decades of materials development traditionally used for semiconductor technologies. This advance will expand the scope of IBM and the Institute of Bioengineering and Nanotechnology’s collaborative program, allowing scientists to simultaneously pursue multiple methods for creating materials to improve medicine and drug discovery. An industry and institute collaboration of this scale brings together the minds and resources of several leading scientific institutions to address the complex challenges in making practical nanomedicine solutions a reality.
The full research paper was published today in the peer-reviewed journal Advanced Functional Materials DOI: 10.1002/adfm.201301307.
Seymour's loss is IBM's gain.
About time!
How that connection/collaboration was not established earlier on begs the question.
Shilling scam gold stocks like Osceola, such a fickle business:
http://www.siliconinvestor.com/readmsg.aspx?msgid=31519085&personmsgnum=1
SEC Charges Penny Stock “Mailman” With Scalping Investors In Gold Mining Stocks
FOR IMMEDIATE RELEASE
2018-38
SEC Complaint
sec.gov
Washington D.C., March 9, 2018 —
The Securities and Exchange Commission has charged a penny stock promoter based in Florida with defrauding investors in a pair of gold mining stocks by secretly amassing shares before touting the companies publicly. He allegedly sold the bulk of his stock and reaped more than $1.1 million in illicit profits after his promotions caused the share prices and trading volumes to skyrocket.
Shilling scam gold stocks like Osceola, such a fickle business:
http://www.siliconinvestor.com/readmsg.aspx?msgid=31519085&personmsgnum=1
SEC Charges Penny Stock “Mailman” With Scalping Investors In Gold Mining Stocks
FOR IMMEDIATE RELEASE
2018-38
SEC Complaint
sec.gov
Washington D.C., March 9, 2018 —
The Securities and Exchange Commission has charged a penny stock promoter based in Florida with defrauding investors in a pair of gold mining stocks by secretly amassing shares before touting the companies publicly. He allegedly sold the bulk of his stock and reaped more than $1.1 million in illicit profits after his promotions caused the share prices and trading volumes to skyrocket.
BULLSHIT TECH!
Nothing like it!!
Good for NNVC!!!
Great for IBM!!!!
Money in the bank!!!!
Check it out!!!!!
I have urls!!!!!!
This IBM collaboration with NNVC looks profitable:
IBM 158.47 +2.26 +1.45% USD 10:01 AM EST 648.16k - 5.59M 145.98B
I read where up in Canada Corona is going weed all in! I guess they look upon it as a trial run to the USA.
http://money.cnn.com/2017/10/30/investing/constellation-canopy-cannabis/index.html
Booze just can't cut it by comparison and is doomed!! Oh well, breweries had a their innings, now we shall see where weed will be.
Will we all become lifers!?
Weed free or weed me?
$1 or $100?
We shall see where weed will be.
IBM Announces Magic Bullet To Zap All Kinds of Killer Viruses
https://www.fastcompany.com/3059782/ibm-announces-magic-bullet-to-zap-all-kinds-of-killer-viruses
I don't answer questions.
I ask them: did so with Seymour and now with Myers. I'll get back to you when I hear back; should be revealing; then again it might be private.
We'll see what transpires.
I do like Hedrick and Diwan - they think so much alike!!
And just like me!
Viruses and now bacteria don't stand a chance!!
Sorry, I actually believed this:
http://www.siliconinvestor.com/readmsg.aspx?msgid=31516157
I should have cleared this with you first!!
Sorry.